bezafibrate has been researched along with Cholestasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Korf, H; Nevens, F; Smets, L; van der Merwe, S; Verbeek, J | 1 |
| Beuers, U; Hohenester, S | 1 |
| Düll, MM; Kremer, AE | 1 |
| Enjoji, M; Fujino, T; Harada, N; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Machida, K; Maehara, Y; Matsunaga, K; Nakamuta, M; Nakashima, M; Nishinakagawa, T; Taketomi, A; Yada, M; Yada, R; Yasutake, K; Yoshimoto, T | 1 |
| Burns, AM; Gonzalez, FJ; Hays, T; Kennett, MJ; Peters, JM; Rusyn, I; Ward, JM | 1 |
2 review(s) available for bezafibrate and Cholestasis
| Article | Year |
|---|---|
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
Management of Chronic Hepatic Itch.
Topics: Analgesics, Opioid; Anion Exchange Resins; Antipruritics; Bezafibrate; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 Enzyme Inducers; Drainage; Humans; Hypolipidemic Agents; Membrane Glycoproteins; Methylamines; Narcotic Antagonists; Prevalence; Pruritus; Rifampin; Thiazepines; Ursodeoxycholic Acid | 2018 |
1 trial(s) available for bezafibrate and Cholestasis
| Article | Year |
|---|---|
Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; ATP Binding Cassette Transporter, Subfamily B; Bezafibrate; Cholestasis; Drainage; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Jaundice, Obstructive; Liver Cirrhosis, Biliary; Male; Middle Aged; Phospholipids; Polymerase Chain Reaction; PPAR alpha | 2010 |
3 other study(ies) available for bezafibrate and Cholestasis
| Article | Year |
|---|---|
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate.
Topics: Alkaline Phosphatase; Bezafibrate; Bilirubin; Chenodeoxycholic Acid; Cholestasis; Cholesterol; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Pruritus; Treatment Outcome | 2021 |
Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Topics: Acyl-CoA Oxidase; Animals; Bezafibrate; Bile Acids and Salts; Blotting, Northern; Cell Cycle Proteins; Cholestasis; Cytochrome P-450 CYP4A; Disease Models, Animal; DNA Repair Enzymes; DNA-Binding Proteins; Liver Neoplasms; Male; Mice; Peroxisome Proliferators; PPAR alpha; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 2005 |